Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort

JAKi maintained continuation rates and efficacy in second-line treatment compared with first-line treatment, which is potentially advantageous over bDMARDs for patients with RA who require a change in initial therapy.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2025-03-20
DOI
https://doi.org/10.1093/rheumatology/keaf157
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort

Akihiro Tanaka, Kohei Tsujimoto, Chisato Ashida, Yuki Etani et al.
Lara D. Veeken
Rheumatoid Arthritis Research and Therapies
article

Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort

Akihiro Tanaka, Kohei Tsujimoto, Chisato Ashida, Yuki Etani, Atsushi Kumanogoh, Yasutaka Okita, Kosuke Ebina, Motomu Hashimoto, Yuji Nozaki, Satomi Okamura, Tadashi Okano, Seiji Okada, Hideo Onizawa, Iku Shirasugi, Akira Ōnishi, Yonsu Son, Ryota Hara, Takuya Kotani, Wataru Yamamoto, Naoki Nakano, Y Hiramatsu
article en

Abstract

JAKi maintained continuation rates and efficacy in second-line treatment compared with first-line treatment, which is potentially advantageous over bDMARDs for patients with RA who require a change in initial therapy.

Lara D. VeekenVol. 64(7)
Kansai Medical University (JP), Kyoto University (JP), Osaka City University (JP), Japan Science and Technology Agency (JP), Kurashiki Central Hospital (JP), Kindai University Hospital (JP), Osaka University Hospital (JP), Osaka Metropolitan University (JP), Nara Medical University (JP), Kobe University (JP), Osaka University of Pharmaceutical Sciences (JP), Kindai University (JP), The University of Osaka (JP)
Good health and well-being
Openalex Percentile: Top 92%
Rheumatoid Arthritis Research and Therapies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.